Seòmar agus comataidhean

Further to the answer to question S6W-02452 which provided information on the number of people screened for diabetic retinopathy in each month between January 2019 and July 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers The following table provides information on the number of people screened for diabetic retinopathy, in each month of the period that followed, from August 2021 to June 2022:

Further to the answer to question S6W-02449 which provided information on the number of people who attended an abdominal aortic aneurysm screening appointment between January 2019 and July 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers The following table provides information on the number of people who attended an abdominal aortic aneurysm screening in each of the months that followed from August 2021 to June 2022.

The Scottish Government does not hold national data for infectious diseases screening, antenatal haemoglobinopathies screening, or foetal anomaly ultrasound examinations within the pregnancy screening programme. These can be requested directly from individual NHS boards.

Further to the answer to question S6W-02453 which provided information on the number of trisomy screens taken between January 2019 and June 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers The following table provides information on the number of trisomy screens taken each month in the period which followed from July 2021 to June 2022:

The Scottish Government is clear that hate crime and prejudice, including Islamophobia, will not be tolerated.

Our new Hate Crime Strategy will set out our priorities for tackling hate crime in Scotland and will support implementation of the Hate Crime and Public Order (Scotland) Act 2021.

Hate crime legislation sends a message to victims, perpetrators and wider society that hate crime is not acceptable and will not be tolerated. Once in force the Act will build on and strengthen existing protections, including through the creation of new stirring up of hatred offences that will apply to all listed characteristics, including religion.

The Ministerial led Hate Crime Strategic Partnership Group has been established to take this work forward and brings together a range of public and third sector partners. The Terms of Reference have been agreed and published on the Scottish Government’s website: The Hate Crime Strategic Partnership Group - gov.scot (www.gov.scot) .

We continue to engage with Muslim communities across Scotland as we develop the strategy which will consider how we best tackle Islamophobia in Scotland, including whether a definition of Islamophobia would be helpful.

Tackling hate crime remains a priority and we encourage anyone who has experienced or witnessed a hate crime to report it to Police Scotland or through a third party reporting centre.

The Scottish Government does not hold information on the newborn hearing test and newborn infant physical examination. These would need to be requested from health boards directly.

Further to the answer to question S6W-02448 which provided information on the number of babies screened using the bloodspot test in the newborn screening programme for each month between January 2019 and July 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers . The following table provides information on the number of babies screened using the bloodspot test in the newborn screening programme, for each month in the period that followed from August 2021 to June 2022:

NHS Scotland Assure has carried out twenty Key Stage Assurance Reviews (KSARs) since it was established. At the conclusion of the KSAR, NHS Assure advises whether it supports or does not support a project. Where a project is not supported, an action plan is prepared by the responsible Health Board with support from NHS Scotland Assure to address the issues identified. The project can subsequently be reassessed. Twelve of the twenty KSARs resulted in a “supported” decision and eight resulted in a “not supported” decision and work is underway to address the issues identified. Responsibility for approving business cases continues to lie with the Scottish Government.

NHS Scotland Assure has so far supported the following projects at the full business case stage:

There are a range of options available to women who require transvaginal mesh removal surgery. A contract with Spire Healthcare, where Professor Hashim operates, was agreed earlier this year and arrangements for the first patients to travel to Bristol are underway. Furthermore, the Scottish Government can now also confirm that a contract has been agreed with Gynaecologic and Reconstructive Surgery Ltd, Missouri, USA, where Dr Veronikis operates. NHS National Services Scotland will now work closely with NHS GGC and local Health Boards to facilitate the arrangements for those who wish to travel to Bristol or to the USA for mesh removal surgery.

These additional options, alongside the potential for referral to NHS England services, complement the Complex Pelvic Mesh Removal Service in Glasgow. Despite Covid-19, we were able to introduce that service on a phased basis and a number of patients have been seen in the intervening period and have had surgeries carried out. It is expected that NHS Greater Glasgow and Clyde will work towards improving waiting times as services begin to open up more fully.

Medicated grit can only be used under licence administered by a veterinarian. A veterinary prescription is required to purchase flubendazole coated medicated grit and it is recommended following predetermination of worm levels in grouse .

The Veterinary Medicines Directorate (VMD) is the competent authority in the UK responsible for the testing of food producing animals for residues of authorised veterinary medicines products and prohibited substances. The National Residues Surveillance Programme is carried out by VMD in accordance with The Animal and Animal Products (Examination for Residues and Maximum Residue Limits) (England and Scotland) Regulations of 2015. Food Standards Scotland collect samples on behalf of VMD in approved game handling establishments.

The testing of red grouse for the presence of anthelmintic compounds authorised for use in medicated feed, such as flubendazole, has been carried out since 2016 and VMD publish its annual figures on gov.uk.

International science collaboration is vital in both supporting Scotland’s own research and innovation, and in ensuring Scottish expertise contributes to international research addressing global challenges such as the climate and biodiversity crises. Satellite information, including Earth Observation data, is a key resource that underpins this research, and processing it is one of the many strengths of the Scottish space sector. Over the period 2018-2021, the European Commission and European Space Agency provided 8% and 29%, respectively, of Research and Development funding for Scottish Space Companies. Maintaining access to European Programmes such as Copernicus is therefore extremely important to both Scotland’s industry and academic institutes and to the international science community as a whole.

Whilst the Copernicus Climate Change Service has an open data policy meaning data produced by it will therefore remain freely available to UK users, until an agreement on UK participation in Copernicus is finalised, the UK will not be able to participate in the parts of the Copernicus programme that are open only to EU member states. For example, UK-based businesses, academics and researchers will not be able to bid for Copernicus contracts tendered through the EU, funded through the EU’s Multi-annual Financial Framework or through any process using EU procurement rules after December 2020.

UK organisations could previously bid for Copernicus contracts tendered through ECMWF and Mercator Ocean. Until the Copernicus agreement is implemented, UK organisations cannot bid for Copernicus Services contracts except in exceptional circumstances that need to be justified to the European Commission.

The Scottish Government therefore strongly supports the UK’s continued involvement in EU programmes such as Copernicus and continues to liaise with the UK Government on EU programmes to reiterate the impacts of the continued delays.

Spending on active travel will increase throughout Scotland as we realise the Programme for Government commitment to increase the active travel budget to at least £320 million or 10% of the transport budget from 2024-25 onwards. The detail of how that significant increase in investment will apply in different local authority areas is still to be determined.

The Scottish Government supports all local authorities to deliver active travel through a variety of programmes including several run by third sector partners which local authorities can bid into and two direct funds – a LA resource fund of £2 million and a capital fund of £35 million (Cycling Walking and Safer Streets) both distributed pro rata this year across all 32 local authorities.